Back to Search
JOANNA M BRELL MD
MD
Hematology & Oncology Physician
NPI: 1740205350Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35-066467(OH)
Research & Publications (8)
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.
PMID 18670776·Cancer Chemother Pharmacol·2009
3-trial
Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer.
PMID 19258727·Oncology·2009
3-trial
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
PMID 19399502·Cancer Chemother Pharmacol·2009
3-trial
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors.
PMID 19011760·Invest New Drugs·2009
3-trial
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine.
PMID 18414865·Cancer Chemother Pharmacol·2009
3-trial
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles.
PMID 18470481·Invest New Drugs·2008
3-trial
A rare case of melanoma recurring as subcutaneous metastatic melanoma with overlying ecchymoses.
PMID 18427064·Arch Dermatol·2008
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2500 METROHEALTH DR
CLEVELAND, OH 44109 - Phone
- (216) 778-5790
Quick Facts
- NPI
- 1740205350
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile